Amikacin SDRIFE on the basis of neomycin cross-reactivity managed with desensitization and treating through

Ann Allergy Asthma Immunol. 2024 Apr 20:S1081-1206(24)00239-4. doi: 10.1016/j.anai.2024.04.017. Online ahead of print.NO ABSTRACTPMID:38648976 | DOI:10.1016/j.anai.2024.04.017

Source: Annals of Allergy, Asthma and Immunology - April 22, 2024 Category: Allergy & Immunology Authors: Morgan N Vincent Jordon Jaggers Christina Fiske Elizabeth J Phillips Joanna L Stollings Source Type: research